π· The positive ANA, elevated ESR, anemia, and joint tenderness strongly indicate systemic inflammation, which is characteristic of systemic lupus erythematosus.
π· The butterfly rash, alopecia, mouth ulcers, and hyperpigmented lesions are classic SLE manifestations, confirming this autoimmune diagnosis.
π· Teaching avoidance of sunlight is essential, because ultraviolet exposure can trigger flares and worsen skin lesions.
π· Helping the client identify flare triggers improves self-management, reducing the frequency and severity of exacerbations.
π· Monitoring corticosteroid adherence is critical, because steroids control inflammation and prevent life-threatening complications such as renal involvement.
Celiac disease
π· Celiac disease presents with gastrointestinal symptoms, not butterfly rash, alopecia, or joint edema.
π· ANA positivity and systemic inflammation are not characteristic findings.
Type 1 diabetes mellitus
π· This condition does not cause skin plaques, rash, or mucosal ulcerations, which are prominent in SLE.
π· ANA and ESR abnormalities do not indicate diabetes.
Multiple sclerosis
π· MS presents with neurological deficits, not cutaneous rashes, joint edema, or mouth ulcers.
π· The lab findings do not support demyelinating disease.
Recommend low-impact and strength-building exercises
π· Exercise is beneficial but not a priority action, compared to reducing flare triggers and UV exposure.
π· Activity guidance does not address the acute systemic inflammation.
Educate client on carbohydrate counting
π· This applies to diabetes management, not SLE.
π· It does not reduce lupus flare risk.
Remind client to read food labels for gluten
π· This is relevant to celiac disease, not SLE.
π· Gluten avoidance does not affect lupus symptoms.
Diet adherence to prevent exacerbations
π· Diet is not the main driver of lupus flares, unlike in celiac or Crohn's disease.
π· Monitoring focuses more on medication adherence and emotional well-being.
Microvascular complications
π· These are associated with diabetes, not lupus.
π· SLE complications involve kidneys, skin, joints, and immune systemβnot microvasculature.
Changes in cognition
π· Cognitive changes are more closely linked to neurological disorders, not this clientβs presentation.
π· No current symptoms indicate CNS involvement.